Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Семен Михайлович Расин, Игорь Петрович Кайдашев, Михаил Сахнович Расин, Алексей Михайлович РасинfiledCriticalСемен Михайлович Расин
Priority to UAU200910995UpriorityCriticalpatent/UA47974U/en
Publication of UA47974UpublicationCriticalpatent/UA47974U/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
A method for the controlled treatment of Alzheimer disease type I with Pyoglitason in insulin resistant patients provides for long-term use of Pyoglitason at a dose of 15 mg daily in the patients with the early stage of Alzheimer disease type I and diabetes mellitus type 2 or increased C-peptide blood content.
UAU200910995U2009-10-302009-10-30Method for controlled treatment of alzheimer disease type i with pyoglitason in insulin resistant patients
UA47974U
(en)
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level